Skip to content
Novo Nordisk and Cedars-Sinai Medical Center

Novo Nordisk and Cedars-Sinai Medical Center

Liraglutide is a GLP-1 agonist that acts as a peptide therapeutic. Like exenatide, liraglutide is believed to have neuroprotective properties, and it is being studied for its potential to slow the progression of Parkinson’s by reducing cellular damage.

Cart 0

Your cart is currently empty.

Start Shopping